Cardiac Cath Lab team has earned a 2025 Care Outcomes Assessment Program (COAP) Performance Recognition Award for Excellence ...

Diabetes mellitus is highly prevalent in patients with coronary atherosclerosis. As a result of several factors, including a ...

It’s important for clinicians to assess patients undergoing percutaneous coronary intervention (PCI) for both anemia and chronic kidney disease (CKD).

By Sofia Simmons A granddad-of-six has thanked the paramedics who “saved his life” after what he thought was indigestion ...

Among severely frail patients undergoing complex PCI scenarios, mortality rates were 44.2% following cardiac arrest, 51.0% ...

For ST-elevation myocardial infarction, primary percutaneous coronary intervention (PPCI) is superior to thrombolytic therapy and, when available, is the treatment of choice.

"Rather than only focusing on Percutaneous Coronary Intervention, the scope will be expanded to include prevention such as ...

A new study published in the Journal of American Medical Association showed that switching from ticagrelor to clopidogrel one ...

Taking low-dose aspirin can help reduce your risk of heart attack and stroke if you have cardiovascular disease, according to scientists. Aspirin therapy may be beneficial, especially if you have a ...

Measuring coronary inflammation with CT imaging improves long-term risk assessment following percutaneous coronary ...

As generic versions of AstraZeneca’s blockbuster drug ticagrelor prepare to enter the market, The BMJ raises fresh concerns over the integrity of the clinical trials that underpinned its approval.

Understand how IVI guidance reduces PCI complications in complex coronary lesions, outperforming angiography alone.